Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!A salesman who marketed illegal cancer treatments in the U.S. for a Canadian company embroiled in a counterfe…
NICE says 'no' again to Roche's Avastin for ovarian cancer…
Italian antitrust watchdogs have entered the Avastin-vs.-Lucentis fray. The Italian Competition Authority opened an investigation of Roche ($RHHBY) and Novartis ($NVS) on suspicion of a "cartel" desig…
Image courtesy of NPR Chalk up another big win for Hal Barron and his R&D team extraordinaire at Genentech. The FDA today approved a new indication for Roche's ($RHHBY) cancer drug Avastin. The…
